# Ascorbic Acid (Vitamin C) Infusion in Human Sepsis

> **NCT01434121** · PHASE1,PHASE2 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 24 (actual)

## Conditions studied

- Sepsis
- Septic Shock
- Hypotension
- Acute Lung Injury

## Interventions

- **DRUG:** Ascorbic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01434121
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434121, "Ascorbic Acid (Vitamin C) Infusion in Human Sepsis". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01434121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*